Table 2.

Provision of Care that Supports Adherence to Antiretroviral Therapy by HIV Care Providers in the United States.^a,^b

	Sample size	Weighted column %c	95% CI
For patients using ART, discuss treatment adherence at every visit
Most or all	1139	95.5	93.4–97.5
More than half	51	3.8	1.8–5.9
About half	11	0.4d	0.2–0.7
Less than half	2	0.2d	0–0.4
Few or none	2	0.1d	0–0.2
Offer education and advice about tools to increase adherence for patients on ARTe
Most or all	756	60.1	52.9–67.4
More than half	227	17.7	13.8–21.6
About half	96	8.5	6–11
Less than half	85	7.1	4.3–9.9
Few or none	37	6.6	2.7–10.4
Refer patients who are non-adherent to ART for support services as needed
Most or all	738	53.5	45.5–61.5
More than half	213	14.6	11.7–17.6
About half	80	6.3	3.9–8.7
Less than half	72	9.3	6.1–12.6
Few or none	90	16.2	10.2–22.1
Provide all 3 services for most or all patients
Yes	577	42.8	34.6–51.0
No	610	57.2	49.0–65.4

Abbreviations: No., sample size; 95% CI, 95% confidence interval; ART, antiretroviral therapy; MMP, medical monitoring project.

^aN = 1234.

^b2013–2014 MMP provider survey.

^cValues exclude “don’t know” responses.

^dCoefficient of variation is greater than 0.30, estimate may be unreliable.

^eFor example, dose reminder alarms, diaries, and pillboxes.